台股 » 個股 » 健亞 » 籌碼相關 » 券商分點績效

健亞

(4130)
可現股當沖
  • 股價
    22.30
  • 漲跌
    ▼0.15
  • 漲幅
    -0.67%
  • 成交量
    40
  • 產業
    上櫃 生技醫療類股
  • 151人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
健亞 (4130)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/14 ~ 2024/04/28     後一日»

券商獲利排行 - 2024/04/14 ~ 2024/04/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  5.12%3163.1312.9-1649125524.224.224.222.3
  8.09%139.50139.5-7017124.324.324.322.3
  5.54%107.87.2100.6-48328024.324.224.422.3
  7.37%85.70.785-4444824.224.124.222.3
  7.70%83.8083.8-4504524.2024.222.3
  4.33%72.32.669.6-36336924.224.224.222.3
  5.81%65.9-0.966.8-37104724.124.224.122.3
  7.15%60.1060.1-350352402422.3
  7.08%49.50.349.2-2622924.12424.122.3
  9.72%45.6045.6-1901924.7024.722.3
  7.19%44.9044.9-260262402422.3
  7.91%40.2040.2-2002124.224.224.222.3
  7.91%40.2040.2-2102124.2024.222.3
  8.21%39.9039.9-2002024.3024.322.3
  7.77%39.5039.5-2102124.2024.222.3
  6.93%36.8-0.537.2-2112224.124.624.122.3
  5.40%35.2-0.936.1-1972724.124.224.122.3
  7.12%34.91.433.5-1552024.524.324.522.3
  6.77%32.60.232.4-1822024.12424.122.3
  6.35%30.80.830.1-1552024.324.224.322.3
  6.44%28.2028.2-1441824.324.324.322.3
  8.72%27.7027.7-1201324.423.924.422.3
  5.60%27.2-1.628.8-1552024.324.524.222.3
  4.01%25.33.322-11152624.224.124.322.3
  4.09%22.8-1.424.1-13102324.224.324.222.3
  6.74%22.6022.6-1401423.924.423.922.3
  9.16%22.5022.5-1001024.6024.622.3
  7.05%22.10.421.7-1211324.123.724.122.3
  5.67%20.1020.1-1501523.6023.622.3
  8.23%20020-1001024.3024.322.3
  7.52%20020-1101124.1024.122.3
  7.50%19.9019.9-1101124.1024.122.3
  7.45%19.8019.8-1101124.1024.122.3
  7.66%18.5018.5-1001024.2024.222.3
  6.77%17.8017.8-1101123.9023.922.3
  6.22%17.8017.8-1101223.82423.822.3
  5.65%17.8-0.518.2-1031324.224.324.122.3
  7.28%17.5017.5-1001024.1024.122.3
  9.90%17.2017.2-70724.8024.822.3
  6.89%16.5016.5-901024242422.3
  5.66%16.5-1.518-1021224.224.924.122.3
  7.90%15.3015.3-80824.2024.222.3
  5.10%14.7-0.515.2-83122424.12422.3
  7.45%14.4014.4-80824.1024.122.3
  7.44%14.4014.4-80824.1024.122.3
  5.84%14.20.114.1-731024.324.324.322.3
  5.98%12.9-0.313.2-8192424.32422.3
  6.50%12.4012.4-80823.9023.922.3
  8.23%12012-60624.3024.322.3
  7.95%11.6011.6-60624.2024.222.3

券商虧損排行 - 2024/04/14 ~ 2024/04/28

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -7.84%-390.90-390.9206206024.224.2022.3
  -8.04%-118.90-118.96161024.224.2022.3
  -8.47%-72.4-0.9-71.63335224.424.52422.3
  -5.92%-63.9-0.3-63.63745824242422.3
  -2.17%-52.7-2.5-50.1261007424.224.224.222.3
  -7.72%-52.20-52.22828024.224.2022.3
  -7.65%-51.80-51.82828024.124.1022.3
  -6.31%-49.60-49.63333023.823.8022.3
  -9.29%-480-482121024.624.6022.3
  -7.81%-45.40-45.42324024.224.224.122.3
  -7.48%-37.80-37.82121024.124.124.222.3
  -8.97%-37.40-37.41717024.524.5022.3
  -7.52%-32.70-32.71818024.124.1022.3
  -8.08%-31.40-31.41616024.324.3022.3
  -8.02%-29.20-29.21515024.224.2022.3
  -7.02%-27.3-0.7-26.61316324.324.324.122.3
  -7.80%-26.40-26.41414024.224.2022.3
  -2.80%-25.8-5.3-20.59382824.324.424.222.3
  -5.78%-25-0.8-24.214184242423.822.3
  -8.45%-24.70-24.71212024.424.4022.3
  -4.74%-22.9-2.9-2010201024.224.32422.3
  -5.02%-20.7-2.4-18.3917824.224.32422.3
  -8.42%-20.50-20.51010024.424.4022.3
  -8.23%-200-201010024.324.3022.3
  -8.14%-19.80-19.81010024.324.3022.3
  -7.31%-19.7-0.3-19.4911224.424.524.322.3
  -7.17%-190-191011024242422.3
  -6.75%-17.80-17.81111023.923.9022.3
  -9.00%-17.70-17.788024.524.5022.3
  -7.28%-17.50-17.51010024.124.1022.3
  -7.08%-170-179100242424.322.3
  -4.91%-16.7-0.8-15.8814624.224.324.122.3
  -8.42%-16.40-16.488024.424.4022.3
  -6.98%-15.10-15.19902424022.3
  -5.01%-14.60.5-15812424.224.224.322.3
  -7.23%-13.90-13.98802424022.3
  -8.18%-13.90-13.977024.324.3022.3
  -5.77%-13.90.1-14810224.12424.122.3
  -7.13%-13.70-13.78802424022.3
  -7.05%-13.50-13.5880242424.422.3
  -5.60%-13.5-0.4-13.1710324.124.22422.3
  -7.69%-130-1377024.224.2022.3
  -8.79%-12.90-12.966024.524.5022.3
  -7.47%-12.60-12.677024.124.1022.3
  -8.61%-12.60-12.666024.424.4022.3
  -8.54%-12.50-12.566024.424.4022.3
  -1.30%-12.23.9-16.19393024.124.124.222.3
  -8.20%-11.90-11.966024.324.3022.3
  -9.16%-11.30-11.355024.624.6022.3
  -7.60%-110-1166024.124.1022.3
新藥研發 浩鼎子公司抗癌新藥申請一期臨床 健亞明年完成試驗Anue鉅亨-2022/09/12
健亞 相關文章